Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Unallocated Adjustment	-482.76M	-546.56M	-610.23M	-508.12M	-558.57M
Ethical Pharmaceutical Business	61.63B	58.98B	49.59B	43.15B	37.01B
Ethical Pharmaceutical Business Growth	4.49%	18.95%	14.92%	16.60%	23.26%
Others	628.72M	698.18M	751.17M	657.42M	715.07M
Others Growth	-9.95%	-7.05%	14.26%	-8.06%	-10.58%
Consumer Health Care Business	27.38B	28.18B	26.00B	25.09B	22.37B
Consumer Health Care Business Growth	-2.83%	8.39%	3.64%	12.14%	-11.45%
Total	89.16B	87.31B	75.73B	68.38B	59.53B
Total Growth	2.12%	15.30%	10.74%	14.87%	7.38%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Europe	-	-	24.41B	20.15B	20.95B
Europe Growth	-	-	21.11%	-3.82%	38.64%
Japan	36.32B	37.60B	36.75B	36.00B	34.86B
Japan Growth	-3.42%	2.32%	2.09%	3.26%	-4.08%
Other Europe	24.01B	23.35B	-	-	-
Other Europe Growth	2.80%	-	-	-	-
France	10.17B	9.05B	-	-	-
France Growth	12.48%	-	-	-	-
UK	12.41B	11.35B	9.54B	7.33B	-
UK Growth	9.31%	18.97%	30.19%	-	-
Other	6.26B	5.96B	5.03B	4.90B	3.71B
Other Growth	4.95%	18.60%	2.53%	31.95%	-6.72%
Total	89.16B	87.31B	75.73B	68.38B	59.53B
Total Growth	2.12%	15.30%	10.74%	14.87%	7.38%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error